Exhale

The official blog of the Lung Institute.

Remembering D-Day and Honoring Veterans

5 Jun 2015
| Under COPD, Lung Disease, Pneumoconiosis, Treatments | Posted by
| 0 Comments
Remembering D-Day and Honoring Veterans

They Were There for Us. Let’s be Here for Them.

On June 6th, 1944, the Allies invaded Nazi-occupied France, risking everything in one audacious assault to gain a foothold on the continent and begin the long process of pushing Hitler’s forces out of Western Europe. When military service members of our greatest generation stormed the beaches of Normandy seventy-one years ago, they landed in the best physical condition of their lives. Despite months of training and preparation, many fell in action. Sadly, few of those who lived through the events of D-Day remain among us, and many of those still with us suffer from lifelong service-related injuries and illnesses.

Veterans of all our nation’s armed conflicts, those who made such selfless sacrifices, should receive the highest level of care possible throughout their lives. Unfortunately, many veterans’ families see their loved ones’ health decline at a pace Veterans Administration (VA) medical care cannot match. Innovative, alternative therapies exist, but are seldom covered by traditional VA benefits.

Lung Disease and VA Benefits

Prominent among health conditions affecting veterans are lung diseases like chronic obstructive pulmonary disease (COPD) and interstitial lung disease. A VA study found that the prevalence of COPD among veterans is significantly higher than the general population. Those who served in Vietnam faced chemical pollutants such as Agent Orange. Others, such as veterans who served in Iraq and Afghanistan, were regularly subjected to air pollution from burn pits, exploded ordnance and allergens occurring in the cities and deserts of the Middle East. Given the limited resources available through the VA, many of our nation’s warriors have elected to explore alternative treatment options outside VA coverage for their lung disease.

The VA represents the best care the U.S. Government has to offer our veterans, but like any governmental program, it is bound by conventional limits. The status of many of our veterans as elderly dependents, combined with the rare instances of VA approval of innovative solutions to health challenges, often leaves veterans relying on extended family for resources to take advantage of alternative health care solutions.

Take Action to Treat Lung Disease

Using the regenerative properties of adult cells, the Lung Institute can help promote the healing of lungs damaged by disease by promoting the healing of tissue. Cells are harvested from the patient’s own blood or bone marrow, and returned to the patient where they can begin to promote healing. The fetal stem cell controversy so prevalent in the news over the past few years has all but eclipsed the fact that adult cells are present in all of our bodies. Functioning as our body’s system to promote healing, these cells live in blood and bone marrow tissue. They naturally respond to injury or illness. However, cells cannot act quickly enough on their own without outside intervention. Autologous cellular therapy can expedite this natural healing process.

A growing number of veterans’ families are choosing to take care of their elder veterans outside the VA system. The Lung Institute provides personalized care of the highest quality that consistently results in positive outcomes by applying modern best practices to the growing field of regenerative medicine.

The Lung Institute has performed over 800 treatments since our inception two years ago and offers solutions for those struggling to breathe because of lung disease. If you or the veteran you love has been diagnosed with a lung disease and would like to learn more about regenerative treatment options, contact the Lung Institute at (800) 729-3065.

 

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.